ARTICLE | Company News
Bio-Rad Laboratories, Quest Diagnostics deal
October 23, 2000 7:00 AM UTC
BIO.A will regain from DGX exclusive licensing rights to its patents relating to hereditary hemochromatosis. DGX received the rights through its purchase of SmithKline Beecham Clinical Labs in 1999. ...